Commentary: Low hanging fruit—reducing hospital-acquired pressure injuries associated with cardiac surgery

Background: The HeartMate 3 (HM3) left ventricular assist device (LVAD) (Ab- bott, Inc, Chicago, Ill) is a fully magnetically levitated centrifugal implantable pump used to treat patients with chronic heart failure. The MOMENTUM (Multi- center Study of MagLev Technology in Patients Undergoing Mechanical Circula- tory Support Therapy With HeartMate 3) trial demonstrated that patients treated with the HM3 experienced reduced need for reoperation for LVAD replacement compared with a control group receiving an axial flow design, Heartmate II (Ab- bott, Inc). However, there are few reports of using HM3 as the replacement pump in patients who already are supported by a durable LVAD and experience a device - related complication necessitating replacement. p p p Conclusions: LVAD replacement with HM3 can be performed safely and may be considered as the pump of choice in patients requiring LVAD replacement. (J Thorac Cardiovasc Surg 2020;160:1 32-9)